WellSpan Health adopts EHR system to automate discharges at two more facilities

To make the patient discharging process smoother and faster, WellSpan Health, a York, Pennsylvania-based integrated healthcare system, is adopting new technology from Ensocare in two of its facilities.

Manufactured by Ensocare, a care coordination provider in Omaha, Nebraska, the software integrates with and consolidates existing electronic health record (EHR) platforms to foster patient compliance and operational efficiencies while improving the patient experience.

WellSpan has already implemented the software in three of its facilities at WellSpan Surgery & Rehabilitation Hospital and WellSpan York Hospital, both in York, and at WellSpan Gettysburg Hospital in Gettysburg, Pennsylvania, the health system announced in a statement.

WellSpan will add the software to WellSpan Ephrata Community Hospital in Ephrata, Pennsylvania and WellSpan Good Samaritan Hospital in Lebanon, Pennsylvania in early 2017. They will be switching from a manual patient discharge process to Ensocare’s automated system.

The expansion will take the health system one step closer to consolidating its various electronic health record systems into a single platform for all of its facilities.

“The data sharing that’s necessary to ensure continuity of care requires interoperability,” said Luis Castillo, president and CEO of Ensocare, in a statement. “Using the foundational base of the EMR investment, hospitals can integrate the next layer of technology designed specifically to improve care.”

The health system expects to handle nearly 50,000 annual discharges as part of the expansion and save employees time now that they don’t have to manually complete paperwork to discharge patients.

“Connecting the Ensocare technology solution allows WellSpan to facilitate efficient and effective information sharing across its system and earn a spot among most wired hospitals,” Castillo said. “Ensocare’s unique technology solution streamlines the discharge and referral process to transition patients effectively to the next level of care.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup